Independent report
Report of the Commission on Human Medicine’s Expert Working Group on benefit-risk and risk minimisation measures of the yellow fever vaccine
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.
Documents
Details
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.
Updates to this page
Published 21 November 2019